Clinical Trial

A Study to Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia

Name: A Study to Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia — clinical trial record (NCT07421232)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to compare the effectiveness, safety of SYH2053 in Participants with primary hypercholesterolemia or mixed dyslipidemia. A total of 156 Participants were actually enrolled

Trial Details

NCT Number	NCT07421232
Lead Sponsor	CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Conditions	Hypercholesterolemia and Mixed Hyperlipidemia
Enrollment	156 participants
Start Date	2024-12-03
Primary Completion	2025-08-30 (estimated)
Study Completion	2026-02-12 (estimated)
Updated on ClinicalTrials.gov	2026-02-19